Simplex Trading’s Lantern Pharma LTRN Stock Holding History

Simplex Trading’s Portfolio LTRN Stock Details LTRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$822	Sell	600 -1,000	-63%	-$2.8K	﹤0.01%	8641
2025 Q4	$4.85K	Hold	1,600	–	–	﹤0.01%	7449
2025 Q3	$6K	Sell	1,600 -2,900	-64%	-$12.1K	﹤0.01%	8202
2025 Q2	$14K	Sell	4,500 -10,100	-69%	-$34.1K	﹤0.01%	7065
2025 Q1	$51K	Buy	+14,600	New	+$60.6K	﹤0.01%	5754
2024 Q4	–	Sell	-6,700	Closed	-$24K	–	9150
2024 Q3	$24K	Sell	6,700 -600	-8%	-$2.47K	﹤0.01%	6532
2024 Q2	$34K	Sell	7,300 -3,800	-34%	-$22.9K	﹤0.01%	6452
2024 Q1	$97K	Buy	11,100 +8,900	+405%	+$47.6K	﹤0.01%	5612
2023 Q4	$9K	Buy	+2,200	New	+$7.76K	﹤0.01%	7515
2023 Q2	–	Sell	-4,700	Closed	-$22K	–	9524
2023 Q1	$22K	Buy	+4,700	New	+$24.7K	﹤0.01%	6818
2022 Q1	–	Sell	-200	Closed	-$1K	–	10983
2021 Q4	$1K	Buy	+200	New	+$1.83K	﹤0.01%	10204

Other funds holding LTRN

BCM

BIOS Capital Management Fort Worth, Texas $52.9M AUM 30.51% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

WIM

Westside Investment Management Santa Monica, California $653M AUM 28.36% 1-Year Est. Return

Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Simplex Trading's LTRN Position: Q1 2026 in Review

Simplex Trading reduced its Lantern Pharma (LTRN) stake by 95% in Q1 2026, selling an estimated $6.01K and leaving 107 shares worth $146. The position accounts for ﹤0.01% of the portfolio, ranked #8855.

Simplex Trading first reported a position in LTRN in Q1 2022 and has held it in 9 quarters since. The position peaked at $25K in Q1 2024. 33 funds tracked by Wall St. Rank hold LTRN as of Q1 2026.

Simplex Trading held 107 shares of Lantern Pharma worth $146 as of Q1 2026.
Simplex Trading sold 2,150 Lantern Pharma shares in Q1 2026, an estimated $6.01K.
Lantern Pharma made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #8855 holding.
Simplex Trading first reported a position in Lantern Pharma in Q1 2022 and has held it in 9 quarters since.
Simplex Trading's Lantern Pharma position peaked at $25K in Q1 2024.
33 funds tracked by Wall St. Rank held Lantern Pharma as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.